| scholarly article | Q13442814 |
| P50 | author | Apostolos Polykratis | Q62838164 |
| P2093 | author name string | Jean Delbé | |
| José Courty | |||
| Panagiotis Katsoris | |||
| Zoi Diamantopoulou | |||
| Yamina Hamma-Kourbali | |||
| Oya Bermek | |||
| P2860 | cites work | Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta | Q22253290 |
| Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis | Q24314425 | ||
| Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN | Q24322051 | ||
| Domain structure of pleiotrophin required for transformation | Q28142793 | ||
| Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin | Q28208159 | ||
| Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth | Q28216536 | ||
| Characterization of heparin affin regulatory peptide signaling in human endothelial cells | Q28242363 | ||
| Differential induction of glioblastoma migration and growth by two forms of pleiotrophin | Q28252154 | ||
| High affinity binding and overlapping localization of neurocan and phosphacan/protein-tyrosine phosphatase-zeta/beta with tenascin-R, amphoterin, and the heparin-binding growth-associated molecule | Q28265073 | ||
| Multi-ligand interactions with receptor-like protein tyrosine phosphatase beta: implications for intercellular signaling | Q28270605 | ||
| 6B4 proteoglycan/phosphacan, an extracellular variant of receptor-like protein-tyrosine phosphatase zeta/RPTPbeta, binds pleiotrophin/heparin-binding growth-associated molecule (HB-GAM) | Q28565680 | ||
| Src protein-tyrosine kinase structure and regulation | Q30160814 | ||
| Involvement of heparin affin regulatory peptide in human prostate cancer | Q31909575 | ||
| PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model | Q32069431 | ||
| Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Conne | Q33301092 | ||
| Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice | Q36067348 | ||
| Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer | Q38323421 | ||
| Heterogeneity of the chondroitin sulfate portion of phosphacan/6B4 proteoglycan regulates its binding affinity for pleiotrophin/heparin binding growth-associated molecule. | Q38352991 | ||
| A basic peptide derived from the HARP C-terminus inhibits anchorage-independent growth of DU145 prostate cancer cells | Q40087892 | ||
| RNA interference targeting protein tyrosine phosphatase zeta/receptor-type protein tyrosine phosphatase beta suppresses glioblastoma growth in vitro and in vivo | Q40241308 | ||
| Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastoma | Q40403714 | ||
| Heparin affin regulatory peptide is a key player in prostate cancer cell growth and angiogenicity | Q40415486 | ||
| An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors | Q40819536 | ||
| Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant | Q42798861 | ||
| Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase. | Q42812907 | ||
| Dominant negative effectors of heparin affin regulatory peptide (HARP) angiogenic and transforming activities | Q42813705 | ||
| The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities | Q42832601 | ||
| Identification of heparin affin regulatory peptide domains with potential role on angiogenesis | Q47328872 | ||
| Isolation from bovine brain and structural characterization of HBNF, a heparin-binding neurotrophic factor | Q48239145 | ||
| Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin | Q48639103 | ||
| Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3) | Q53952099 | ||
| Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth | Q72135965 | ||
| Prostate cancer epidemiology | Q73138981 | ||
| An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis | Q73306250 | ||
| HARP induces angiogenesis in vivo and in vitro: implication of N or C terminal peptides | Q73661959 | ||
| Heparin-binding growth-associated molecule contains two heparin-binding beta -sheet domains that are homologous to the thrombospondin type I repeat | Q73731319 | ||
| Endothelial cell proliferation induced by HARP: implication of N or C terminal peptides | Q74027801 | ||
| Relationship between serum concentrations of the growth factor pleiotrophin and pleiotrophin-positive tumors | Q77425401 | ||
| Correlation of elevated plasma levels of two structurally related growth factors, heparin affin regulatory peptide and midkine, in advanced solid tumor patients | Q80998521 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 224 | |
| P577 | publication date | 2010-08-25 | |
| P1433 | published in | Molecular Cancer | Q15724585 |
| P1476 | title | A Pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPβ/ζ | |
| P478 | volume | 9 |
| Q39316539 | Implications of pleiotrophin in human PC3 prostate cancer cell growth in vivo. |
| Q36418808 | Loss of receptor protein tyrosine phosphatase β/ζ (RPTPβ/ζ) promotes prostate cancer metastasis |
| Q35701268 | Midkine: a promising molecule for drug development to treat diseases of the central nervous system |
| Q38832365 | Pleiotrophin exerts its migration and invasion effect through the neuropilin-1 pathway |
| Q33915644 | The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells |
Search more.